Cover Image
市場調查報告書

全球戒煙藥市場:2016∼2020年

Global Smoking Cessation Drugs Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 357354
出版日期 內容資訊 英文 74 Pages
訂單完成後即時交付
價格
Back to Top
全球戒煙藥市場:2016∼2020年 Global Smoking Cessation Drugs Market 2016-2020
出版日期: 2016年04月27日 內容資訊: 英文 74 Pages
簡介

抽煙的不良影響相關意識高漲,許多吸煙者努力戒煙或減少抽煙量。在這樣的過程中,戒煙產品在人與人之間擴展。全球戒煙藥市場,預計2016∼2020年,以年複合成長率18.16%擴大。

本報告提供全球戒煙藥市場現狀與至2020年的成長預測,市場趨勢與課題,各地區趨勢,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 全球香煙統計:年度平均每個人的消費量

第6章 流行病學

第7章 抽煙對健康的影響

第8章 香煙的法律規章

  • 戒煙帶給企業的影響
  • 對個人的經濟負擔

第9章 開發平台分析

第10章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第11章 各類型市場區隔

  • 全球戒煙藥物市場
  • 全球NRT市場
  • 全球e-香煙市場

第12章 各取得性市場區隔

  • 處方藥
  • OTC藥

第13章 各地區市場市場區隔

  • 各地區市場
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第14章 推動市場的要素

  • 吸煙者的增加
  • 十幾歲吸煙者的增加
  • 民間認識計劃數
  • 對香煙風險的認識高

第15章 促進要素的影響

第16章 市場課題

  • 藥物及治療的副作用
  • 治療後的再開始
  • 藥物研究開發的脆弱

第17章 促進要素與課題的影響

第18章 市場趨勢

第19章 供應商環境

  • 競爭模式
  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American
  • 其他值得注意的供應商

第20章 附錄

第21章 關於Technavio

圖表

目錄
Product Code: IRTNTR8278

About Smoking Cessation Products

Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking.

Technavio's analysts forecast the global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American

Other Prominent Vendors

  • 22nd Century Group
  • Alkalon
  • Altria Group
  • Aradigm
  • Arena Pharmaceuticals
  • Ballantyne Brands
  • British American Tobacco (BAT)
  • CB Distributors
  • Cytos Biotechnology
  • Electronics Cigarettes International Group (Victory Electronic Cigarettes)
  • Evotec
  • Gamucci
  • Japan Tobacco
  • Johnson & Johnson
  • LOGIC Technology
  • NAL Pharmaceuticals
  • Nicotek
  • Novartis
  • Revolymer
  • RR Chemicals
  • Selecta Biosciences
  • Target
  • The Harvard Drug Group
  • Vapor
  • VMR Products
  • Walgreens
  • Wal-Mart
  • White Cloud

Market driver

  • High awareness of risks associated with tobacco use
  • For a full, detailed list, view our report

Market challenge

  • Relapse after treatment
  • For a full, detailed list, view our report

Market trend

  • Ban on tobacco advertisements
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: World cigarette statistics: Per capita consumption per year

PART 06: Epidemiology

  • US

PART 07: Health implications of smoking

  • Risk of tobacco smoke on non-smokers

PART 08: Regulations on tobacco use

  • Impact of smoking bans on businesses
  • Economic benefits to individuals

PART 09: Pipeline analysis

  • NAL2762
  • X-22
  • APD356
  • GSK598809
  • SEL-068
  • ARD-1600

PART 10: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 11: Market segmentation by type

  • Global smoking cessation drugs market
  • Global NRTs market
  • Global e-cigarette market

PART 12: Market segmentation by availability

  • Prescription products
  • OTC products

PART 13: Geographical segmentation

  • Global smoking cessation products market by geography 2015-2020
  • Smoking cessation products market in Americas
  • Smoking cessation products market in EMEA
  • Smoking cessation products market in APAC

PART 14: Market drivers

  • Increase in number of smokers
  • Increase in teenage smoking
  • Significant number of public awareness programs
  • High awareness of risks associated with tobacco use

PART 15: Impact of drivers

PART 16: Market challenges

  • Side effects associated with drugs and therapies
  • Relapse after treatment
  • Weak R&D on drugs

PART 17: Impact of drivers and challenges

PART 18: Market trends

  • Increase in use of e-cigarettes
  • Increased innovation in smoking cessation products
  • Ban on tobacco advertisements
  • Increased pictorial warnings on cigarette packages

PART 19: Vendor landscape

  • Competitive scenario
  • GlaxoSmithKline
  • Imperial Tobacco
  • NJOY
  • Pfizer
  • Reynolds American
  • Other prominent vendors

PART 20: Appendix

  • List of abbreviations

PART 21: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Common health effects caused by smoking
  • Exhibit 03: Smoking cessation products: Pipeline portfolio
  • Exhibit 04: Discontinued projects
  • Exhibit 05: Global smoking cessation products market 2015-2020 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global smoking cessation products market by type
  • Exhibit 08: Global smoking cessation products market by type 2015
  • Exhibit 09: Global smoking cessation drugs market 2015-2020 ($ billions)
  • Exhibit 10: Global NRTs market 2015-2020 ($ billions)
  • Exhibit 11: Global NRTs market by product 2015
  • Exhibit 12: Global nicotine patch market 2015-2020 ($ billions)
  • Exhibit 13: Nicotine patch market by geographical region 2015
  • Exhibit 14: Global nicotine gum market 2015-2020 ($ billions)
  • Exhibit 15: Nicotine gum market by geographical region 2015
  • Exhibit 16: Global e-cigarette market 2015-2020 ($ billions)
  • Exhibit 17: Global e-cigarette market: Product life cycle analysis 2015
  • Exhibit 18: E-cigarette market by geographical region 2015
  • Exhibit 19: Global smoking cessation products market by availability
  • Exhibit 20: Global smoking cessation products market by geography 2015
  • Exhibit 21: Global smoking cessation products market by geography 2020
  • Exhibit 22: Global smoking cessation products market revenue by geography 2015-2020 ($ billions)
  • Exhibit 23: Smoking cessation products market in Americas 2015-2020 ($ billions)
  • Exhibit 24: Smoking cessation products market in EMEA 2015-2020 ($ billions)
  • Exhibit 25: Smoking cessation products market in APAC 2015-2020 ($ billions)
  • Exhibit 26: Impact of drivers
  • Exhibit 27: Impact of drivers and challenges
  • Exhibit 28: Implementation of picture warnings in various countries
  • Exhibit 29: GlaxoSmithKline: Business segmentation by revenue 2014
  • Exhibit 30: GlaxoSmithKline: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 31: GlaxoSmithKline: Geographical segmentation by revenue 2014
  • Exhibit 32: GlaxoSmithKline: Key takeaways
  • Exhibit 33: Imperial Tobacco: Business segmentation by revenue 2014
  • Exhibit 34: Imperial Tobacco: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 35: Imperial Tobacco: Key takeaways
  • Exhibit 36: NJOY: Product categories
  • Exhibit 37: NJOY: Key takeaways
  • Exhibit 38: Pfizer: Business segmentation by revenue 2014
  • Exhibit 39: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 40: Pfizer: Geographical segmentation by revenue 2014
  • Exhibit 41: Pfizer: YoY growth and revenue of Chantix or Champix ($ millions)
  • Exhibit 42: Pfizer: Key takeaways
  • Exhibit 43: Reynolds American: Business segmentation by revenue 2014
  • Exhibit 44: Reynolds American: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 45: Reynolds American: Key takeaways
Back to Top